Agilent India, Trivitron Healthcare to open lab at IIT Chennai Science Park

Agilent provides its latest analytical technologies to help Trivitron and enable the needs of clinical customers. This association will help ensuring better health preparedness for the Indian population


Agilent Technologies India has announced its collaboration with Trivitron Healthcare to establish a world class Partner Lab situated within the campus of Indian Institute of Technology (IIT), Chennai Science Park. Newer technologies are getting introduced into the field of clinical diagnostics in healthcare segment and more recently there has been a keen interest in using high end analytical technologies to diagnose the disease more accurately, rapidly and with enhanced sensitivity in comparison to the current day solutions.

As a part of this association, the Partner lab is equipped with some of the high end technologies like UHPLC, LC MS/MS, qPCR's from Agilent, through which Trivitron aims to develop end to end solutions using these analytical platforms in a cost effective way making them accessible and affordable for clinical testing markets in emerging countries like India.

Commenting on this collaboration Dr Pasupathi Siva Kumar, country manager, Life Science Group & Chemical Analysis Group, Agilent technologies India said "The healthcare sector is extremely important for a country especially like India. There is a constant need to introduce newer technologies in the area of clinical research that will enable the diagnosis of disease more accurately and at a more rapid pace. As a part of the association, Agilent will provide its latest analytical technologies to establish a world class lab within the campus of IIT Chennai Science Park. With this collaboration with Trivitron Healthcare we hope to ensure better health preparedness for the Indian population"

Dr G S K Velu, managing director, Trivitron Healthcare, India said "With three of the world class manufacturing facilities for IVD Reagents located in India and Finland, partnership with world leader Agilent Technologies for Instrument platforms will enable us to offer a wider specialized area of clinical testing and is a great addition to Trivitron's portfolio. With the benefit of Agilent's analytical capabilities and expertise, Trivitron will work to innovate and develop Diagnostics kits in several areas like Carrier Screening, Pre Natal Screening, New Born Screening, Drug Monitoring, Vitamin Profiling, Biogenic Amines, Homocysteine, Carbohydrate Deficient Transferrin (CDT) etc. Three decades of expertise and R&D experience of Trivitron's subsidiary Labsystems Diagnostics Finland will act as a catalyst for this collaboration using Agilent's high end analytical technologies."


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email